Side effect | Probability (%) | Range (%) |
---|---|---|
IMRT cardiac toxicity | 0.95 | 0.05–2.58 |
IMRT CL breast cancer | 0.04 | 0.02–0.06 |
IMRT lung cancer | 0.57 | 0.08–0.84 |
STD-VMAT cardiac toxicity | 0.97 | 0.05–2.54 |
STD-VMAT CL breast cancer | 0.11 | 0.06–0.23 |
STD-VMAT lung cancer | 0.63 | 0.08–0.95 |
NC-VMAT cardiac toxicity | 0.89 | 0.05–2.34 |
NC-VMAT CL breast cancer | 0.08 | 0.02–0.20 |
NC-VMAT lung cancer | 0.54 | 0.07–0.89 |
MA-VMAT cardiac toxicity | 0.89 | 0.05–2.31 |
MA-VMAT CL breast cancer | 0.09 | 0.04–0.20 |
MA-VMAT lung cancer | 0.55 | 0.07–0.92 |
TOMO cardiac toxicity | 0.98 | 0.07–2.39 |
TOMO CL breast cancer | 0.10 | 0.06–0.22 |
TOMO lung cancer | 0.72 | 0.11–1.18 |
MIXED cardiac toxicity | 0.86 | 0.05–2.22 |
MIXED CL breast cancer | 0.07 | 0.03–0.15 |
MIXED lung cancer | 0.63 | 0.08–1.01 |
IMPT cardiac toxicity | 0.40 | 0.04–0.84 |
IMPT CL breast cancer | 0.003 | 0.00–0.007 |
IMPT lung cancer | 0.22 | 0.03–0.60 |